Latest Radiopharmacology Stories
Nuclear Medicine / Radiopharmaceuticals Market report broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012 and forecast to 2017.
DUBLIN, January 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tz54gw/european_nuclear) has announced the addition of the "European
DUBLIN, January 3, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2q5v4f/radiopharmaceutica) has announced the addition of the "Global
DUBLIN, December 27, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tn88ln/nuclear_medicine) has announced the addition of the "Global
RadioMedix Inc. (Houston, TX) received the exclusive authorization for the U.S. distribution of the 68Ge/68Ge generators produced by ITG Isotope Technologies Garching GmbH (Germany).
Nuclear Medicine Market & Radiopharmaceuticals Market report covers competitive landscape and key developments of major players, pipeline analysis, investment opportunities, and regulatory
Asia-Pacific Nuclear Medicine/Radiopharmaceutical Market report studies the Asia-Pacific nuclear medicine market over the forecast period of 2012 - 2017.
The global market for molecular imaging devices was valued at $2 billion in 2012 and is expected to reach $2.2 billion in 2013.
Transparency Market Research published a new "Global Radiopharmaceuticals Market – Industry Analysis, Size, Share, Trends and Forecast, 2012 – 2018" market research report to its